melarsoprol has been researched along with Recrudescence in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (18.52) | 18.7374 |
1990's | 3 (11.11) | 18.2507 |
2000's | 14 (51.85) | 29.6817 |
2010's | 5 (18.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaka, JT; Kazumba, LM; Ngoyi, DM; Tshala-Katumbay, D | 1 |
Kennedy, A; Lutje, V; Seixas, J | 2 |
Büscher, P; Karhemere Bin Shamamba, S; Mumba Ngoyi, D; Ngay Lukusa, I; Pyana Pati, P; Van Reet, N | 1 |
Betu Ku Mesu Kande, V; Boelaert, M; Lutumba, P; Nyamowala, G; Robays, J; Sese, C; Van der Veken, W | 1 |
Büscher, P; Kaiser, M; Karhemere Bin Shamamba, S; Mumba Ngoyi, D; Ngay Lukusa, I; Pyana, PP; Van Reet, N | 1 |
Mpia, B; Pépin, J | 2 |
Kager, PA; Mendonça Melo, M; Rasica, M; Richter, C; van Thiel, PP; Wismans, PJ | 1 |
Boa, F; Dje, NN; Doua, F; Miezan, TW | 1 |
Büscher, P; Etchegorry, MG; Legros, D; Lejon, V; Mbulamberi, D; Savignoni, A | 1 |
Kaboya, JS; Kibona, SN; Lubega, GW; Matemba, L | 1 |
Franco, JR; Jannin, J; Louis, FJ; Ndongo, P; Nguema, E; Simarro, PP | 1 |
Bisser, S; Būscher, P; Lejon, V; Miaka Mia Bilenge, C; N'Siesi, FX; Preux, PM; Van Nieuwenhove, S | 1 |
Checkley, AM; Gibson, WC; Jäger, HR; Mabey, DC; Pepin, J; Taylor, MN | 1 |
Abel, PM; Krishna, S; Woodrow, CJ | 1 |
Poltera, AA | 1 |
Boa Yapo, F; Doua, F | 1 |
Doua, F; Yapo, FB | 1 |
Bouteille, B; Dumas, M | 1 |
Enyaru, JC; Kaminsky, R; Legros, D; Matovu, E; Schmid, C; Seebeck, T | 1 |
Enyaru, JC; Gallati, S; Geiser, F; Kaminsky, R; Mäser, P; Matovu, E; Schneider, V; Seebeck, T | 1 |
Brun, R; Burri, C; Kunz, C; Schmid, C; Schumacher, R | 1 |
Bales, JD; Harrison, SM; Mbwabi, DL; Schecter, PJ | 1 |
Abinya, A; Chumo, DA; Dola, S; Mbwabi, D; Reardon, MJ; Siongok, TA; Smith, DH; Wanyama, L; Wellde, BT | 1 |
Guern, C; Milord, F; Pepin, J; Schechter, PJ | 1 |
Champalimaud, JL; Medina, EA; Ventura, FA | 1 |
3 review(s) available for melarsoprol and Recrudescence
Article | Year |
---|---|
Chemotherapy for second-stage human African trypanosomiasis.
Topics: Animals; Antiprotozoal Agents; Drug Therapy, Combination; Eflornithine; Humans; Melarsoprol; Nifurtimox; Pentamidine; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2013 |
Chemotherapy for second-stage Human African trypanosomiasis.
Topics: Animals; Antiprotozoal Agents; Drug Therapy, Combination; Eflornithine; Humans; Melarsoprol; Nifurtimox; Pentamidine; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2010 |
Human trypanosomiasis in the Ivory Coast: therapy and problems.
Topics: Animals; Cote d'Ivoire; Eflornithine; Humans; Melarsoprol; Pentamidine; Recurrence; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1993 |
4 trial(s) available for melarsoprol and Recrudescence
Article | Year |
---|---|
Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis.
Topics: Adolescent; Adult; Congo; Drug Administration Schedule; Drug Therapy, Combination; Eflornithine; Female; Humans; Injections, Intravenous; Male; Melarsoprol; Middle Aged; Recurrence; Treatment Outcome; Trypanocidal Agents; Trypanosomiasis | 2002 |
Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
Topics: Adolescent; Adult; Animals; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Female; Humans; Immunoglobulin M; Latex Fixation Tests; Leukocyte Count; Male; Melarsoprol; Middle Aged; Pentamidine; Recurrence; Risk Factors; Treatment Failure; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2003 |
Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
Topics: Adolescent; Adult; Animals; Drug Administration Schedule; Female; Humans; Leukocyte Count; Lymph Nodes; Male; Melarsoprol; Proportional Hazards Models; Recurrence; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2006 |
Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Topics: Administration, Oral; Adult; Animals; Brain Diseases; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Melarsoprol; Nifurtimox; Recurrence; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2007 |
20 other study(ies) available for melarsoprol and Recrudescence
Article | Year |
---|---|
Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Democratic Republic of the Congo; Disease Management; Drug Therapy, Combination; Eflornithine; Female; Hospital Records; Humans; Male; Melarsoprol; Middle Aged; Multivariate Analysis; Nifurtimox; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African; Young Adult | 2018 |
Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
Topics: Adult; Animals; Aquaglyceroporins; Base Sequence; Democratic Republic of the Congo; DNA, Protozoan; Drug Resistance; Female; Genotype; Humans; Melarsoprol; Mice; Molecular Sequence Data; Mutant Chimeric Proteins; Mutation; Pentamidine; Phenotype; Recurrence; Sequence Analysis, DNA; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2014 |
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Democratic Republic of the Congo; Female; Humans; Infant; Male; Melarsoprol; Middle Aged; Recurrence; Treatment Failure; Trypanocidal Agents; Trypanosomiasis, African | 2008 |
Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice.
Topics: Adaptation, Biological; Animals; Antiprotozoal Agents; Blood; Cerebrospinal Fluid; Female; Humans; Male; Melarsoprol; Mice; Recurrence; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2011 |
[Three patients with African sleeping sickness following a visit to Tanzania].
Topics: Africa; Animals; Fatal Outcome; Female; Humans; Male; Melarsoprol; Middle Aged; Netherlands; Recurrence; Tanzania; Travel; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2002 |
[Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
Topics: Animals; Antibodies, Protozoan; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Cote d'Ivoire; Follow-Up Studies; Humans; Melarsoprol; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2002 |
Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
Topics: Animals; Diminazene; Drug Resistance; Humans; Mass Screening; Melarsoprol; Phenanthridines; Recurrence; Suramin; Tanzania; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2006 |
The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea.
Topics: Agglutination Tests; Animals; Disease Outbreaks; Disease Vectors; Endemic Diseases; Equatorial Guinea; Fluorescent Antibody Technique, Indirect; Humans; Melarsoprol; Pentamidine; Population Surveillance; Prevalence; Recurrence; Rural Health; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2006 |
Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
Topics: Adult; Animals; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Melarsoprol; Polymerase Chain Reaction; Recurrence; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2007 |
Randomized, controlled trial of treatments for second-stage sleeping sickness.
Topics: Animals; Drug Therapy, Combination; Humans; Melarsoprol; Nifurtimox; Randomized Controlled Trials as Topic; Recurrence; Treatment Failure; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2007 |
Chemotherapy, relapses and CNS in experimental African trypanosomiasis.
Topics: Animals; Central Nervous System; Chlorocebus aethiops; Chloroquine; Melarsoprol; Mice; Recurrence; Trypanosoma brucei brucei; Trypanosomiasis, African | 1983 |
[Current therapy of trypanosomiasis].
Topics: Adenosylmethionine Decarboxylase; Animals; Arsenicals; Deoxyadenosines; Drug Resistance; Eflornithine; Enzyme Inhibitors; Hospitalization; Humans; Melarsoprol; Pentamidine; Randomized Controlled Trials as Topic; Recurrence; Suramin; Triazines; Trypanocidal Agents; Trypanosomiasis, African | 1994 |
[Current status of trypanosomiasis].
Topics: Africa; Animals; Autoantibodies; Blood-Brain Barrier; Brain Diseases; Follow-Up Studies; Forecasting; Humans; Incidence; Melarsoprol; Nitroimidazoles; Pentamidine; Population Surveillance; Protozoan Vaccines; Recurrence; Social Problems; Socioeconomic Factors; Survival Rate; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African | 1997 |
Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
Topics: Animals; DNA, Protozoan; Drug Resistance; Eflornithine; Humans; Melarsoprol; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African; Uganda | 2001 |
Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy.
Topics: Adenosine; Animals; Carrier Proteins; Cerebrospinal Fluid; Drug Resistance; Genetic Variation; Humans; Melarsoprol; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Recurrence; Sequence Analysis, DNA; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2001 |
The phenomenon of treatment failures in Human African Trypanosomiasis.
Topics: Africa, Eastern; Animals; Dose-Response Relationship, Drug; Drug Resistance; Humans; Melarsoprol; Mice; Muridae; Parasitic Sensitivity Tests; Recurrence; Treatment Failure; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2001 |
Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
Topics: Adult; Animals; Arsenicals; Drug Therapy, Combination; Eflornithine; Female; Humans; Kenya; Male; Melarsoprol; Middle Aged; Recurrence; Suramin; Trypanosoma brucei brucei; Trypanosomiasis, African | 1989 |
Treatment of Rhodesian sleeping sickness in Kenya.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Arsenicals; Child; Drug Resistance; Female; Follow-Up Studies; Humans; Kenya; Male; Melarsoprol; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1989 |
Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness.
Topics: Administration, Oral; Adolescent; Animals; Arsenicals; Child; Child, Preschool; Diarrhea; Drug Resistance; Eflornithine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Melarsoprol; Recurrence; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1987 |
Computer-assisted tomographic findings in a patient with African trypanosomiasis.
Topics: Brain Diseases; Child, Preschool; Diminazene; Humans; Male; Melarsoprol; Meningoencephalitis; Recurrence; Tomography, X-Ray Computed; Trypanosomiasis, African | 1986 |